QbD Guided Central Composite Design Optimized RP-HPLC Method for Teneligliptin Assay in Dosage Forms
Current Trends in Biotechnology and Pharmacy · 09.06.2026 · 20 (2a) · 39-49
DOI: 10.5530/ctbp.2026.2s.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Trends in Biotechnology and Pharmacy, online erschienen am 09.06.2026. Verfasst von Srinivasa Rao Yarguntla und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yarguntla, S. R., Dadi, V., Koppisetty, B. R. B., Karanam, S. R., Gandi, A., & Peela, M. (2026). QbD Guided Central Composite Design Optimized RP-HPLC Method for Teneligliptin Assay in Dosage Forms. Current Trends in Biotechnology and Pharmacy, 20(2a), 39-49. https://doi.org/10.5530/ctbp.2026.2s.4
Vancouver
Yarguntla SR, Dadi V, Koppisetty BRB, Karanam SR, Gandi A, Peela M. QbD Guided Central Composite Design Optimized RP-HPLC Method for Teneligliptin Assay in Dosage Forms. Current Trends in Biotechnology and Pharmacy. 2026;20(2a):39-49. doi:10.5530/ctbp.2026.2s.4
BibTeX
@article{Yarguntla2026,
author = {Yarguntla, Srinivasa Rao and Dadi, Vasudha and Koppisetty, Bhagavan Rajesh Babu and Karanam, Sridevi Ranjitha and Gandi, Anusha and Peela, Mounica},
title = {QbD Guided Central Composite Design Optimized RP-HPLC Method for Teneligliptin Assay in Dosage Forms},
journal = {Current Trends in Biotechnology and Pharmacy},
year = {2026},
volume = {20},
number = {2a},
pages = {39--49},
doi = {10.5530/ctbp.2026.2s.4}
}
EUVIMED